---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-015730"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2022-04-26T23:59:59+00:00"
generated_at: "2026-06-26T04:41:57.218469+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Fulgent Genetics completes $170M acquisition of Symphony Buyer via merger

## Summary
- Total purchase price of approximately $170 million, subject to customary adjustments for closing cash, indebtedness, working capital, and expenses.
- Acquisition closed on April 26, 2022; Symphony becomes wholly owned subsidiary of Fulgent Genetics.
- Deal originally announced via merger agreement dated April 16, 2022; stockholders of Symphony consented to the merger.
- Consideration includes upfront cash per share plus contingent rights to escrow and post-closing adjustments.
- Merger was effected through merger of a Fulgent subsidiary (Merger Sub) into Symphony, with Symphony surviving.

## SEC filing metadata
- accession: 0001564590-22-015730
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2022-04-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000156459022015730/0001564590-22-015730-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000156459022015730/flgt-8k_20220426.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-015730
- JSON: https://secwatch.observer/filing/0001564590-22-015730.json
- Plain text: https://secwatch.observer/filing/0001564590-22-015730.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.